Can the genotoxicity of chemotherapy be predicted?
Pui
Ching-Hon
CH
St Jude Children's Research Hospital, Memphis, TN 38105, USA. Ching-hon.pui@stjude.org
Relling
Mary V
MV
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D017930:Genes, Reporter; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics; D009154:Mutation / Q000187:drug effects*; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000235:genetics; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D059005:Topoisomerase II Inhibitors
D000970:Antineoplastic Agents; D059005:Topoisomerase II Inhibitors; D007041:Hypoxanthine Phosphoribosyltransferase